Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis. [electronic resource]
Producer: 20111207Description: 566-74 p. digitalISSN:- 1865-8652
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents -- administration & dosage
- Aza Compounds -- administration & dosage
- Child
- Child, Preschool
- Conjunctivitis, Bacterial -- drug therapy
- Double-Blind Method
- Female
- Fluoroquinolones
- Haemophilus Infections -- drug therapy
- Haemophilus influenzae -- drug effects
- Humans
- Infant
- Male
- Microbial Sensitivity Tests
- Middle Aged
- Moxifloxacin
- Ophthalmic Solutions -- administration & dosage
- Pneumococcal Infections -- drug therapy
- Quinolines -- administration & dosage
- Staphylococcal Infections -- drug therapy
- Staphylococcus aureus -- drug effects
- Streptococcus pneumoniae -- drug effects
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.